ipoGoogle News
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision - indiaipo.in
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision indiaipo.in
GN1 hour ago
Read More//
MARTIN_HARRIS_LABS · Health Care · Martin and Harris Laboratories Limited Unlisted / Pre-IPO Share Price
As of 05 Aug 2026, the Martin and Harris Laboratories Limited unlisted share price is ₹895 per share (+1.01%). Martin and Harris Laboratories Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE03VV01015.
▼ ₹1,035 (−53.63%) over all time
Key figures for Martin and Harris Laboratories Limited
Martin & Harris Laboratories Limited is a pharmaceutical company engaged in contract manufacturing and branded formulations, historically associated with the Apeejay Stya group. The company’s portfolio spans therapeutic segments including anti-infectives, pain management, respiratory and gastro-intestinal. Facilities and quality systems align with Indian regulatory standards, and the company collaborates with distribution partners for domestic reach. Corporate materials trace legacy brands and manufacturing capabilities supporting scale, compliance and patient accessibility across selected markets.
Martin and Harris Laboratories Limited shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Martin and Harris Laboratories Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Martin and Harris Laboratories Limitedshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Martin and Harris Laboratories Limited has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Martin and Harris Laboratories Limited is INE03VV01015. Contact our desk for the latest status and a live quote before you invest.
Martin and Harris Laboratories Limited is an unlisted company operating in the Health Care sector (Pharmaceuticals). Martin & Harris Laboratories Limited is a pharmaceutical company engaged in contract manufacturing and branded formulations, historically associated with the Apeejay Stya group. The company’s portfolio spans therapeutic segments including anti-infectives, pain management, respiratory and gastro-inte…
The current unlisted market price is ₹886.05 per share with a market capitalisation of approximately ₹358 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
Wall Street Week Ahead: Markets brace for Federal Reserve rate decision indiaipo.in
Invest in US Stocks from India – US Stock Market Today upstox.com
Anthropic selects Nasdaq for IPO amid AI risk concerns indiaipo.in
As of 05 Aug 2026, the Martin and Harris Laboratories Limited unlisted (pre-IPO) share price is ₹895 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy Martin and Harris Laboratories Limited unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Martin and Harris Laboratories Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Martin and Harris Laboratories Limited has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Martin and Harris Laboratories Limited.
The ISIN for Martin and Harris Laboratories Limited unlisted shares is INE03VV01015. You will need this ISIN when the shares are credited to your demat account.
Martin and Harris Laboratories Limited unlisted shares have a face value of ₹10 and a typical minimum lot of 100 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Martin and Harris Laboratories Limited price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Martin and Harris Laboratories Limited can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Martin and Harris Laboratories Limited.